ACTRN12615001242516已完成3 期
A prospective, double-blind, randomised, placebo-controlled study to evaluate the efficacy of a complementary medicine formulation,to treat symptoms of Benign Prostatic Hyperplasia (BPH) in otherwise healthy male adults.
Amanda Rao0 个研究点目标入组 100 人开始时间: 2015年11月12日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 45 Years 至 80 Years（—）
- 性别
- Male
入选标准
- •* Male aged between 45-80 years
- •* Medically diagnosed with BPH
- •* Minimum score of 8 in the IPSS
- •* Capable of providing informed consent
- •* Able to attend the required clinics
排除标准
- •* Known hypersensitivity to herbal drugs/nutritional supplement/ foods
- •* Have used a drug/natural therapy for BPH or other urological symptoms within the last 30 days?
- •* Have had urogenital surgery within the last 6 months?
- •* Have had bladder biopsy and/or cystoscopy and biopsy within the past 30 days?
- •* Have been diagnosed with chronic persistent local pathology (e.g. interstitial cystitis, bladder stones)? Receiving/ prescribed Coumadin (Warfarin) or other anticoagulation therapy
- •* Diagnosed genital anatomical deformities, uncontrolled diabetes mellitus, and history of spinal cord injury, uncontrolled psychiatric disorder, and/or abnormal secondary sexual characteristics
- •* Diagnosed prostatic cancer or benign hypertrophy; if suspected by the investigator, refer for medical assessment
- •* Current or history of chronic alcohol and/or drug abuse
研究者
相似试验
进行中（未招募）
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathyumbosacral radiculopathyEUCTR2019-002632-90-PLOlainfarm AS458
进行中（未招募）
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathyEUCTR2019-002632-90-LVOlainfarm AS458
进行中（未招募）
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathyumbosacral radiculopathyEUCTR2019-002632-90-CZOlainfarm AS458
已完成
4 期
A double-blind, randomised, placebo-controlled study to evaluate the safety and efficacy of Sambucol liquid formulation to reduce the duration and severity of the common cold and flu symptoms in adults.Treatment of common coldTreatment of InfluenzaAlternative and Complementary Medicine - Herbal remediesInfection - Other infectious diseasesACTRN12615000506594Prof Luis Vitetta200
进行中（未招募）
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathyEUCTR2019-002632-90-BGOlainfarm AS458